X9 Ultrasound System
Ultrasound Imaging For Vascular Access For Hemodialysis. 510(k) K251673, from X9, Inc. (Wallingford, CT). Product code SGH, class 2.
As of Nov 20, 2026, K251673 is an FDA 510(k) held by X9, Inc., substantially equivalent on Oct 17, 2025 after 140 days, with no recalls tied to it in FDA's recall database.
- Review time: 140 days
- Recalls: 0
The X9 Ultrasound System is intended for ultrasound imaging of validated vascular accesses for hemodialysis during the preliminary stage of a cannulation procedure, prior to inserting the needle. The device is intended to be used by qualified healthcare professionals in a medical setting.
- BD Prevue II Peripheral Vascular Vascular Access SystemK211193 · Bard Access Systems, Inc. (C.R. Bard, Inc.) · Jun 25, 2021
- On FDA's list of AI-enabled devicesFDA AI-enabled medical devices
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- May 30, 2025
- Review panel
- Radiology
- Regulation
- 21 CFR 892.1560
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files